No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs9564355 |
chr13:67434161-67434162 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs567851878 |
chr13:67434165-67434166 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs147554525 |
chr13:67434222-67434223 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs567974538 |
chr13:67434240-67434241 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs180888902 |
chr13:67434254-67434255 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs546957408 |
chr13:67434303-67434304 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs566892715 |
chr13:67434311-67434312 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs185398862 |
chr13:67434378-67434379 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs558628854 |
chr13:67434423-67434424 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs568969663 |
chr13:67434424-67434425 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs536323545 |
chr13:67434443-67434444 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs141977929 |
chr13:67434512-67434513 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs535273449 |
chr13:67434539-67434540 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs556782591 |
chr13:67434635-67434636 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs573730441 |
chr13:67434730-67434731 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs145806352 |
chr13:67434763-67434764 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs552955932 |
chr13:67434808-67434809 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs572814730 |
chr13:67434835-67434836 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs544976542 |
chr13:67434841-67434842 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs564984165 |
chr13:67434859-67434860 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs190802774 |
chr13:67434896-67434897 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs112249617 |
chr13:67434898-67434899 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs554839696 |
chr13:67434904-67434905 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs544323259 |
chr13:67434909-67434910 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs61448207 |
chr13:67434970-67434971 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs114789904 |
chr13:67435029-67435030 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs547288203 |
chr13:67435037-67435038 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs567025178 |
chr13:67435049-67435050 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs532546518 |
chr13:67435074-67435075 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs552193974 |
chr13:67435090-67435091 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs554577827 |
chr13:67435096-67435097 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs568907075 |
chr13:67435130-67435131 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs113115397 |
chr13:67435174-67435175 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs537975732 |
chr13:67435198-67435199 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs554625774 |
chr13:67435240-67435241 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs567466693 |
chr13:67435278-67435279 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs536030113 |
chr13:67435314-67435315 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs376314122 |
chr13:67435331-67435332 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs149284514 |
chr13:67435351-67435352 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs181717501 |
chr13:67435355-67435356 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs572931954 |
chr13:67435358-67435359 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs377393192 |
chr13:67435383-67435384 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs187088289 |
chr13:67435390-67435391 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs574717271 |
chr13:67435404-67435405 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs540567510 |
chr13:67435409-67435410 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs575291443 |
chr13:67435423-67435424 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs9529149 |
chr13:67435462-67435463 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs544359331 |
chr13:67435466-67435467 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs565023613 |
chr13:67435490-67435491 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs560788163 |
chr13:67435550-67435551 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|